Yondelis y Doxil . J&J ( Ortho ) y Pharma Mar consiguieron el año pasado la Patente Mundial como Tratamiento AntiCancerigeno en Combinacion .

ANTICANCER TREATMENTS

Patent number: WO2006046080

Publication date: 2006-05-04

Inventor: GILLES ERARD (US); STERNAS LARS-AXEL (US); TRIFAN OVID (US); VAN DE VELDE HELGI (BE); TEITELBAUM APRIL (US)

Applicant: PHARMA MAR SA (ES); ORTHO BIOTECH PRODUCTS L P (US); RUFFLES GRAHAM KEITH (GB); GILLES ERARD (US); STERNAS LARS-AXEL (US); TRIFAN OVID (US); VAN DE VELDE HELGI (BE); TEITELBAUM APRIL (US)

Classification: - international: A61K47/48; A61K47/48; -

european: A61K47/48W6D

Application number: WO2005GB50189 20051026

Priority number(s): US20040622163P 20041026


Abstract of WO2006046080
A method of treating the human body for cancer comprises administering an effective therapeutic amount of a Pegylated Liposomal form of the anthracycline Doxorubicin ("PLD"), in combination with an effective therapeutic amount of ET-743 .